| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 90.15B | 90.03B | 89.66B | 88.85B | 82.32B | 71.50B |
| Gross Profit | 17.40B | 16.62B | 16.59B | 15.09B | 12.88B | 11.51B |
| EBITDA | 9.55B | 8.99B | 9.69B | 8.98B | 8.14B | 7.02B |
| Net Income | 2.69B | 1.15B | 2.93B | 3.05B | 2.13B | 2.08B |
Balance Sheet | ||||||
| Total Assets | 75.58B | 81.69B | 79.40B | 76.03B | 71.53B | 65.04B |
| Cash, Cash Equivalents and Short-Term Investments | 10.69B | 14.33B | 12.42B | 12.01B | 9.97B | 9.30B |
| Total Debt | 11.10B | 16.45B | 12.66B | 12.46B | 13.59B | 11.54B |
| Total Liabilities | 31.54B | 37.88B | 33.46B | 34.02B | 33.57B | 30.66B |
| Stockholders Equity | 41.46B | 40.87B | 43.27B | 39.54B | 35.62B | 32.23B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.82B | 830.00M | 4.36B | -1.14B | 2.45B |
| Operating Cash Flow | 0.00 | 8.04B | 6.63B | 8.84B | 3.52B | 5.34B |
| Investing Cash Flow | 0.00 | -5.38B | -5.83B | -4.47B | -3.99B | -2.85B |
| Financing Cash Flow | 0.00 | -814.00M | -640.00M | -2.78B | 753.00M | -2.81B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥526.52B | 8.11 | 8.58% | 2.62% | 8.21% | 72.79% | |
74 Outperform | ¥81.10B | 8.59 | ― | 3.85% | -1.01% | 8.57% | |
69 Neutral | ¥111.82B | 12.01 | ― | 5.78% | 1.24% | 186.45% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥24.79B | 24.22 | ― | 4.20% | 0.41% | -59.51% | |
56 Neutral | ¥6.32B | 8.84 | ― | 2.64% | 19.30% | 56.43% | |
55 Neutral | ¥2.75B | 24.21 | ― | 3.03% | 2.78% | ― |